Targeting Upregulated cIAP2 in SOX10-Deficient Drug Tolerant MelanomaMOLECULAR CANCER THERAPEUTICSIF5.52023-06-216OA
Transglutaminase-2 is elevated in the invasive cell state and modulates the tumor immune microenvironment in cutaneous melanomaCANCER RESEARCHIF16.62023-04-040PRE
Targeting SOX10-deficient cells to reduce the dormant-invasive phenotype state in melanomaNATURE COMMUNICATIONSIF15.72022-03-1641OAAI
SOX10 requirement for melanoma tumor growth is due, in part, to immune-mediated effectsCELL REPORTSIF6.92021-12-0116OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向